MediNect Ophtho (@medinectbio) 's Twitter Profile
MediNect Ophtho

@medinectbio

We are a collaborative preclinical CRO, with a primary focus on in vivo studies of retinal diseases.

ID: 1639014602208952320

linkhttp://www.medinect.co.uk calendar_today23-03-2023 21:22:14

15 Tweet

26 Followers

51 Following

MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

Excited to attend the #ARVO2023 conference next week and connect with leading retinal disease researchers. As a preclinical CRO, I'm looking forward to engaging in insightful discussions and advancing our collective understanding of ocular diseases. #ophthalmology #research

MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

New #newsletter on LinkedIn about preclinical in vivo models of #retinaldisease. Our first edition includes advantages/disadvantages of mouse models for #diabeticretinopathy. We offer these models & expert advice. Check it out! linkedin.com/pulse/choosing…

MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

Less than a week to #ARVO2023. Come visit us at Booth #1248 to learn more about us (and check out some more cool images like this OIR Tuft) #RetinalDisease #preclinicalCRO #Belfast

Less than a week to #ARVO2023. Come visit us at Booth #1248 to learn more about us (and check out some more cool images like this OIR Tuft)

#RetinalDisease #preclinicalCRO #Belfast
MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

Cancelled Delta flight from Dublin yesterday. New flight booked to #NewOrleans with Aer Lingus. Connecting flight in NYC cancelled with a 10 (ten) hour delay before cancellation. Running on empty and no sleep but we’re FINALLY on a flight to #NewOrleans. See you soon #ARVO2023

MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

Our CEO James is at #Climb23 today at #LeedsDock. Connect on LinkedIn or in here to meet up!! #preclinical #scaleup #networking

Our CEO James is at #Climb23 today at #LeedsDock.

Connect on LinkedIn or in here to meet up!!

#preclinical #scaleup #networking
MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

The countdown is on! One week from today, the MediNect team will be at #ARVO2024! Get in touch to meet us there to chat all things preclinical: medinect.co.uk/contact-8 #ARVO #OphthalmologyResearch #PreclinicalCRO

The countdown is on! One week from today, the MediNect team will be at #ARVO2024! Get in touch to meet us there to chat all things preclinical: medinect.co.uk/contact-8

#ARVO #OphthalmologyResearch #PreclinicalCRO
MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

🔬Excited for #ARVO2024 Day 1! Join us at Poster B0220 where Dr. Kevin Harkin will present our validation of the subretinal fibrosis model, an exciting model for fibrosis in nAMD. Visit from 13:00-14:45 to learn more. See you there! #VisionResearch #Preclinical #Collaboration

🔬Excited for #ARVO2024 Day 1! 

Join us at Poster B0220 where Dr. Kevin Harkin will present our validation of the subretinal fibrosis model, an exciting model for fibrosis in nAMD. Visit from 13:00-14:45 to learn more. See you there! #VisionResearch #Preclinical #Collaboration
MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

🔬Fantastic #ARVO2024 Day 1! Such interest & great feedback on our subretinal fibrosis model presented by Dr Kevin Harkin, developed by the esteemed researchers Queen's University Belfast 🎓 Reach out to us to book a follow-up meeting here @ ARVO! #AMD #partnering #new #preclinicalCRO

🔬Fantastic #ARVO2024 Day 1!       

Such interest &amp; great feedback on our subretinal fibrosis model presented by Dr Kevin Harkin, developed by the esteemed researchers <a href="/QUBelfast/">Queen's University Belfast 🎓</a> 

Reach out to us to book a follow-up meeting here @ ARVO!  

#AMD #partnering #new #preclinicalCRO
MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

Want to learn more about the subretinal fibrosis model and THE model for anti-VEGF non-responders? Comment on here to book a follow-up meeting at #ARVO2024!! #RETINA #Collaboration #preclinicalCRO #nAMD #subretinalfibrosis medinect.co.uk/subretinal-fib… Alan Stitt ReinholdMedinaLab

MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

🧬 At MediNect we work with biopharma to develop new drugs for people suffering from blindness 🐁 Animal models have been vital in advancing drug development 🔄 We continue to apply the 3Rs—Refine, Reduce, Replace—to minimise animal use #AnimalStats #3Rs #OpennessInAnimalResearch

MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

🧫 We’re developing a new 3D model to better replicate human biology without using animals. 🔬 This system supports drug discovery while advancing the 3Rs—especially Replacement. 🌱 Proud to push for more ethical, human-relevant science #AnimalStats #3Rs #OpennessInAnimalResearch

MediNect Ophtho (@medinectbio) 's Twitter Profile Photo

In 2024 we received a grant from DTFF to get equipment to establish a new 3D model without animals. #AnimalStats #3Rs #OpennessInAnimalResearch